Skip to main content
OpenTrials

Clinical trial condition

Nasopharyngeal Carcinoma

Explore clinical trials studying Nasopharyngeal Carcinoma. Study availability and eligibility vary by location and protocol.

237 public trials 79 recruiting studies
Refine in advanced search Browse all conditions

Nasopharyngeal Carcinoma trial results

Active, Not Recruiting

PD-1 Blockade Combined With De-intensified Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma

NCT04907370

Conditions
Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China
  • First People's Hospital of Foshan Foshan, Guangdong, China
  • Panyu central hospital Guangzhou, Guangdong, China
View Trial Details
Active, Not Recruiting

A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

NCT04974398

Conditions
Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations
  • City of Hope Duarte, California, United States
  • Winship Cancer Institute/Emory University Atlanta, Georgia, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View all 56 locations
View Trial Details
Active, Not Recruiting

Regulation of Blood-Brain Barrier Permeability by APOE Gene Polymorphism and Its Impact on Cognitive Function Post-Radiotherapy in Nasopharyngeal Carcinoma: An MRI Study

NCT06881225

Conditions
Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations
  • Department of Medical Imaging, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangzhou, Guangdong, China
View Trial Details
Active, Not Recruiting

Cadonilimab (PD-1/CTLA-4 Bispecific Blockade) and Chemoradiotherapy in Nasopharyngeal Carcinoma (GEMSTONE)

NCT05587374

Conditions
Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Cancer, +12 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • The First Affiliated Hospital of University of Science and Technology of China Hefei, Anhui, China
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
View all 18 locations
View Trial Details

Related conditions